Journal of Pharmaceutical Investigation

The Korean Society of Pharmaceutical Sciences and Technology (한국약제학회)
권호 표지
DOI QR코드

DOI QR Code

A pH-specific Released Formulation Study of WHW Extract for Therapeutics of Renal Failures

신부전 치료제 WHW 엑스의 pH 특이적인 방출 제형 연구

  • Published : 2009.08.20
Download PDF
⟨ Previous Next ⟩

Abstract

Effective therapeutics for renal failures have not yet been developed until now. Recently, there was a report showing that Wen-pi-tang-Hab-Wu-ling-san (WHW) prescriptions had the potential to prevent renal failures through the increased expression of HSP-27 and HSP-72 after ischemia/reperfusion. Therefore, formulation studies by pH-specific released systems were carried out to exhibit the optimal activity of WHW prescriptions in this study. WHW prescriptions were separately extracted using water into two parts of stomach-released (SR) and intestine-released (IR) extracts. Subsequently, the double-layered tablet was prepared using the SR extracts and pharmaceutical additives and enteric-coated IR tablet. Dissolution studies were carried out to figure out the release of cinnamic acid and icarrin from SR tablet, IR tablet and double-layered tablet, respectively. The complete release of cinnamic acid from SR tablet showed 90min after dissolution in pH 1.2 and insignificant drug released from IR tablet. As well as, icarrin from IR tablet completely released in pH 6.8 and 7.4 as enteric-coating film dissolved.

Keywords

References

  1. J.Y. Guh, H.C. Chen, J.F. Tsai and L.Y. Chuang, Herbal therapy is associated with the risk of CKD in adults not using analgesics in Taiwan, Am. J. Kidney Disl., 49(5), 626-633 (2007). https://doi.org/10.1053/j.ajkd.2007.02.259
  2. P. Wesolowski, M. Saracyn, Z. Nowak and Z. Wankowicz, Peritoneal dialysis and insulin resistance in patients with chronic kidney disease due to nondiabetic nephropathy, Pol. Merkur. Lekarski., 24, 359-363 (2008).
  3. Y. Naiki, Y. Maeda, K. Matsuo, S. Yonekawa, M. Sakaguchi, I. Iwamoto, H. Hasegawa and A. Kanamaru, Involvement of TGF-beta signal for peritoneal sclerosing in continuous ambulatory peritoneal dialysis, J. Nephrol., 16, 95-102 (2003).
  4. Y.M. Seok, J. Kim, M.J. Park, Y.C. Boo, Y.K. Park and K.M. Park, Wen-pi-tang-Hab-Wu-ling-san attenuates kidney fibrosis induced by ischemia/reperfusion in mice, Phytother Res., 22(8), 1057-1063 (2008). https://doi.org/10.1002/ptr.2440
  5. H.W. Jung, C.H. Yoon, Y.H. Kim, Y.C. Boo, K.M. Park and Y.K. Park, Wen-Pi-Tang-Hab-Wu-Ling-San extract inhibits the release of inflammatory mediators from LPS-stimulated mouse macrophages, J. Ethnopharmacol., 114(3), 439-445 (2007). https://doi.org/10.1016/j.jep.2007.08.035
  6. Y.M. Seok, J. Kim, K.C. Choi, C.H. Yoon, Y.C. Boo, Y. Park and K.M. Park, Wen-pi-tang-Hab-Wu-ling-san attenuates kidney ischemia/reperfusion injury in mice. A role for antioxidant enzymes and heat-shock proteins, J. Ethnopharmacol., 112(2), 333-340 (2007). https://doi.org/10.1016/j.jep.2007.03.015
  7. 박용기, 윤철호, 박권무, 부용출, 신부전 예방 및 치료용 약제 학적 조성물 (Pharmaceutical composition for preventing andtreatmenting from disease related to renal failure) KR10-0770634 (2006).
  8. A. Gawron-Gzella, E. Witkowska-Banaszczak and M. Dudek, Herbs and herbal preparations applied in the treatment of gastric hyperacidity, gastric and duodenal ulcer in cigarette smokers, Przegl Lek., 62(10), 1185-1187 (2005).
  9. 약전분과회 편저, 한국약학대학협의회, 대한약전 제9개정 해설서, 신일상사 (2008).
  10. 식약청고시 2005-57호, 의약품둥 기준 및 시험방법 심사의뢰서 심사규정 (별표 6)
  11. S.Y. Lin, K.H. Lin and M.J. Li, Formulation design of double-layer in the outer shell of dry-coated tablet to modulate lag time and time-controlled dissolution function: studies on micronized ethylcellulose for dosage form design (VII), AAPS J., 6(3), article 17 (2004). https://doi.org/10.1208/aapsj060317